Cargando…
Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis
BACKGROUND: The urokinase receptor (uPAR) governs several functions necessary during invasion and metastasis such as motility, degradation of the extracellular matrix and adhesion. This receptor has been recently associated with clinical prostate cancer progression. Experimentally, inhibition of uPA...
Autores principales: | Sehgal, Inder, Foster, Timothy P, Francis, Joseph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560166/ https://www.ncbi.nlm.nih.gov/pubmed/16928272 http://dx.doi.org/10.1186/1475-2867-6-21 |
Ejemplares similares
-
The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells
por: Lejeune, Danielle, et al.
Publicado: (2006) -
A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines
por: Hasanuzzaman, Mohammad, et al.
Publicado: (2007) -
New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
por: Clark, Jonathan CM, et al.
Publicado: (2010) -
Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
por: Akoury, Elie, et al.
Publicado: (2019) -
Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis
por: Peng, Hao, et al.
Publicado: (2019)